Abbott Laboratories (Pakistan) Limited (PSX:ABOT)

PSX:ABOT Revenue

Abbott Laboratories (Pakistan) had revenue of 20.63B PKR in the quarter ending September 30, 2026, with 4.09% growth. This brings the company's total for the last twelve months to 77.83B, up 3.99% year-over-year. In the year 2025, Abbott Laboratories (Pakistan) had annual revenue of 75.40B with 10.59% growth. That makes Abbott Laboratories (Pakistan) the 14,973rd largest company in the world by revenue and 73rd in Pakistan.

• Revenue (ttm): 77.83B
• Revenue Growth: +3.99%
• P/S Ratio: 1.26
• Revenue / Employee: 56.40M
• Employees: 1,380
• Market Cap: 96.91B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical 53.33B 70.7%
• Nutritional 15.02B 19.9%
• Diagnostic 5.34B 7.1%
• Others 1.70B 2.3%

By Geography

Chart

• Pakistan 72.75B 96.5%
• Afghanistan 1.55B 2.1%
• Switzerland 994.86M 1.3%
• Bangladesh 60.04M 0.1%
• Sri Lanka 44.26M 0.1%

Fiscal year ended Dec 31, 2025 See the full PSX:ABOT breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	75.40B	7.22B	10.59%
Dec 31, 2024	68.18B	12.70B	22.90%
Dec 31, 2023	55.48B	6.22B	12.62%
Dec 31, 2022	49.26B	6.69B	15.71%
Dec 31, 2021	42.57B	7.29B	20.65%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error